RNA Manufacturing Videos
-
The Current State Of The mRNA Supply-Chain — In Brief
4/24/2023
In this Bioprocess Online Live panel, we discuss the current state of the mRNA supply chain for critical raw materials and manufacturing supplies and where pain points still exist.
-
Establishing Analytical Methods For Emerging mRNA-Based Therapies
6/5/2023
Here, we describe the use of cutting-edge technologies to assess critical quality attributes of both mRNA drug substances and drug products.
-
Modular Liquid Nanoparticle (LNP) Systems
12/6/2024
Optimize your lipid nanoparticle (LNP) production with KNAUER's modular systems. Maximize flexibility, scalability, and control to meet the needs of your project.
-
Polysarcosine-Functionalized LNPs For Therapeutic mRNA Delivery
4/14/2022
Discover how polysarcosine-functionalized lipid nanoparticles are transforming mRNA delivery. Join Dr. Heinrich Haas of BioNTech as he unveils innovative research and its implications for therapeutic breakthroughs.
-
Maximize Quality Assurance Through Rapid Sterility Testing
9/10/2024
This webinar explores mitigating the risk of product loss, and production delays, as well as the critical role rapid sterility testing plays in ensuring the quality and safety of cell therapy products.
-
Assessing The Manufacturability Of Prospective Lead mRNA Candidates
4/24/2023
In this Bioprocess Online Live panel discussion, experts share the most important factors to consider when assessing the manufacturability of novel linear mRNA candidates in order to bring forward the most successful lead candidates.
-
RNA Vaccine Development To Phase I
4/14/2022
Dr. John Lewis, Founder and CEO, Entos Pharmaceuticals, presents RNA Vaccine Development to Phase I.
-
How Filter Plates Can Streamline Your Workflow
1/25/2022
In this webinar you will learn how to choose the best filter plate for your specific applications and understand pore size, membrane material, well volumes and tip types.
-
Scope 3 Emissions: Cut The Complexity With Creative Collaboration
11/20/2024
Delve into the crucial role of Scope 3 emissions in the biopharma industry's sustainability journey, and learn more about the challenges and opportunities of managing these types of emissions.
-
Can A Small Plasmid Produce Huge Benefits? The Power Of Small
1/17/2023
With benefits across applications, nanoplasmids are designed to replace antiquated bacterial backbones, while eliminating antibiotic markers that can cause regulatory concerns.